BCL-2-interacting mediator of cell death (Bim) is a novel biomarker for response to anti-PD-1 therapy in patients with advanced melanoma

Immunotherapy. 2016 Dec;8(12):1351-1353. doi: 10.2217/imt-2016-0100. Epub 2016 Oct 27.
No abstract available

Keywords: Bim; PD-1; PD-L1; T cell; immunotherapy; melanoma.

Publication types

  • Editorial
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Bcl-2-Like Protein 11 / analysis*
  • Biomarkers, Tumor / analysis*
  • Humans
  • Melanoma / drug therapy*
  • Programmed Cell Death 1 Receptor / antagonists & inhibitors*

Substances

  • Antineoplastic Agents
  • Bcl-2-Like Protein 11
  • Biomarkers, Tumor
  • PDCD1 protein, human
  • Programmed Cell Death 1 Receptor